Observe
Collect price structure, filings, estimates, news, ownership signals, and the macro backdrop before forming a view.
AlphaVue does not treat a ticker and a prompt as research. It builds an evidence trail, assigns competing analytical roles, records uncertainty, and defines what would change the thesis.
Research workflow
Each stage has a distinct job and leaves an auditable output for the next.
Collect price structure, filings, estimates, news, ownership signals, and the macro backdrop before forming a view.
Bull, bear, valuation, and risk roles challenge assumptions, source quality, and alternative explanations.
Reconcile the evidence into a directional stance, time horizon, confidence level, and explicit downside case.
Track catalysts, earnings, price breaks, and new disclosures against predeclared thesis-change conditions.
Evidence coverage
Coverage shows the target share of reports in which each evidence family is checked when relevant and available.
Revenue quality, margins, cash generation, balance-sheet resilience, and operating drivers.
Multiples, cash-flow assumptions, peer context, and the expectations already embedded in price.
Trend, volatility, volume, liquidity, and support or resistance relevant to timing.
Reported results, guidance, revisions, surprise history, and forward consensus dispersion.
Material company events, product cycles, regulation, litigation, and dated catalysts.
Analyst revisions, institutional positioning, short interest, and crowding indicators.
Rates, currencies, commodities, demand cycles, competition, and sector-specific constraints.
Research output
A research classification, never a standalone instruction to trade.
How strongly the available evidence supports the stated thesis.
The assessed downside profile, independent of directional conviction.
A measurable event or threshold that requires the thesis to be revisited.
Confidence and risk
Evidence is consistent and key downside channels appear contained; monitoring remains required.
The thesis is well supported, but volatility, leverage, valuation, or event exposure can still produce severe loss.
Downside appears limited, yet evidence is sparse or conflicting; patience may be more useful than a strong call.
Uncertainty and downside reinforce each other; the report should emphasize avoidance, sizing restraint, and verification.
Known limitations
Methodology FAQ
No. AlphaVue is an AI-assisted research product, not a registered investment adviser or broker-dealer. Its outputs are research reference, not personalized advice.
It summarizes source quality, evidence agreement, and unresolved contradictions. It does not represent the probability that a stock will rise or that a trade will profit.
Confidence concerns support for the thesis; risk concerns possible loss. A well-supported view can still involve leverage, expensive valuation, illiquidity, or binary events.
No. The system checks evidence families when they are relevant and available. Missing or stale inputs should reduce confidence and be disclosed, not silently imputed.
They are preserved as competing cases. The decision stage weighs source strength, materiality, time horizon, and the conditions under which either case would become dominant.
A review is triggered by scheduled events such as earnings and by material changes in price, guidance, estimates, filings, catalysts, or risk conditions.
They use a common framework, but source depth, liquidity, accounting regimes, and business maturity differ. Comparisons should account for those limits.
The report is a starting point for independent research. Verify material facts and consider your own horizon, sizing, costs, constraints, and professional advice before acting.
Continue researching